RNF112 and bladder transitional cell carcinoma: ChIP and dual‐luciferase reporter assays confirmed that in BLCA cells, c‐Myc directly binds to the promoter of ACLY, increasing its transcriptional activity, whereas RNF112 suppresses the transcriptional activity of ACLY.